Comparative safety of JAK inhibitors in patients with rheumatoid arthritis: A network meta-analysis of clinical trials

被引：0
|
作者：
Alves, Carlos [1 ,2 ]
Mendes, Diogo [2 ]
Penedones, Ana [1 ,2 ]
Marques, Francisco Batel [1 ,2 ]
机构：
[1] Univ Coimbra, Sch Pharm, Coimbra, Portugal
[2] AIBILI Assoc Innovat & Biomed Res Light & Image, Coimbra, Portugal
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4457
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [21] SAFETY AND ADHERENCE OF THE JAK INHIBITORS IN CLINICAL PRACTICE IN RHEUMATOID ARTHRITIS
    Valero, C.
    Calvo Garcia, A.
    Garcia Castaneda, N.
    Ortiz, A.
    Llorente, I.
    Varas, B.
    Castaneda, S.
    Garcia de Vicuna, R.
    Ramirez, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1953 - 1954
  • [22] Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials
    Kunwar, Sumit
    Collins, Christopher E.
    Constantinescu, Florina
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [23] Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Janet Pope
    Ruta Sawant
    Namita Tundia
    Ella X. Du
    Cynthia Z. Qi
    Yan Song
    Patrick Tang
    Keith A. Betts
    Advances in Therapy, 2021, 38 : 2750 - 2756
  • [24] Authors' Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
    Pope, Janet
    Sawant, Ruta
    Tundia, Namita
    Du, Ella X.
    Qi, Cynthia Z.
    Song, Yan
    Tang, Patrick
    Betts, Keith A.
    ADVANCES IN THERAPY, 2021, 38 (05) : 2750 - 2756
  • [25] Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials
    Sung, Yoon-Kyoung
    Lee, Young Ho
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2022, 60 (01) : 13 - 23
  • [26] Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate A network meta-analysis
    Ho Lee, Young
    Gyu Song, Gwan
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (03): : 248 - 255
  • [27] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
    Kang, Eun Ha
    Liao, Katherine P.
    Kim, Seoyoung C.
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (07)
  • [28] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
    Eun Ha Kang
    Katherine P. Liao
    Seoyoung C. Kim
    Current Rheumatology Reports, 2018, 20
  • [29] Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
    Harigai, Masayoshi
    RHEUMATOLOGY, 2019, 58 : 34 - 42
  • [30] Comparative efficacy and hematologic safety of different dosages of JAK inhibitors in the treatment of myelofibrosis: a network meta-analysis
    Chen, Ke
    Zhang, Yanyu
    Zou, Jixuan
    Wang, Dehao
    Yu, Xinyue
    Sun, Yan
    Li, Yumeng
    Niu, Jicong
    Chen, Yi
    Zhao, Pei
    Liu, Weiyi
    Lv, Yan
    Wang, Mingjing
    Hu, Xiaomei
    FRONTIERS IN ONCOLOGY, 2024, 14
12345